Oral hypoglycaemic drugs and newer agents use in Type 2 diabetes mellitus
We have reviewed the use of oral agents in the management of Type 2 diabetes, together with their pharmacological mechanisms, indications, side effects and contra-indications. The principal oral agents available for use include metformin, sulphonylureas, non- sulphonylurea secretagogues (meglitinide...
Saved in:
| Main Authors: | P. Joshi, S. Joshi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
AOSIS
2009-02-01
|
| Series: | South African Family Practice |
| Subjects: | |
| Online Access: | https://safpj.co.za/index.php/safpj/article/view/1287 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Improving the Glimepiride Efficacy in Type 2 Diabetes Treatment: A Review of the Potential Advantages and Disadvantages of Glimepiride as Hypoglycemic Oral Medication.
by: Gehad Abdelazeem Elshamy, et al.
Published: (2025-06-01) -
A review of metformin and its place in the diabetes guidelines
by: Gail Mkele
Published: (2013-12-01) -
What’s the latest on sulphonylureas in the management of type 2 diabetes?
by: Gail Mkele
Published: (2013-12-01) -
Where do sulphonylureas fit in the type 2 diabetes guidelines?
by: Gail Mkele
Published: (2014-07-01) -
Modern antihyperglycemic therapy: safety and efficacy of glimepiride
by: Lyudmila Alexandrovna Ruyatkina, et al.
Published: (2012-06-01)